“…DIHE has been reported in the setting of warfarin use with a therapeutic international normalized ratio of 2.5, 3 chronic idiopathic thrombocytopenia, 4 hemophilia A, 5 herpes esophagitis, 6 trauma from food ingestion, 7 trauma from cardioversion, 8 acquired factor XI deficiency in a patient with relapsed T-cell prolymphocytic leukemia after allogenic hematopoietic-cell transplantation, 9 esophageal duplication cyst, 10 after surgical delivery of preterm twins in a preeclamptic woman on therapeutic enoxaparin due to multiple venous thromboembolism risk factors, 11 and after injection sclerotherapy. 12 …”